Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages

Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages

Genome engineering using CRISPR/Cas9 technology enables simple, efficient and precise genomic modifications in human cells. Conventional immortalized cell lines can be easily edited or screened using genome-wide libraries with lentiviral transduction. However, cell types derived from the differentia...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Navarro-Guerrero, E, Tay, C, Whalley, JP, Cowley, SA, Davies, B, Knight, JC, Ebner, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	Springer Nature 2021

Documenti analoghi

Genome-wide CRISPR/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages
di: Elena Navarro-Guerrero, et al.
Pubblicazione: (2021-02-01)

Optimized protocol for CRISPR knockout of human iPSC-derived macrophages
di: Elena Navarro-Guerrero, et al.
Pubblicazione: (2024-03-01)

Generation of two human NRF2 knockout iPSC clones using CRISPR/Cas9 editing
di: Sylvia Merkert, et al.
Pubblicazione: (2023-06-01)

Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing
di: S. Merkert, et al.
Pubblicazione: (2021-01-01)

Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system
di: Mingfeng Guan, et al.
Pubblicazione: (2023-02-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene
di: Bailing Zu, et al.
Pubblicazione: (2021-10-01)

Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus
di: Stefanie Schuster, et al.
Pubblicazione: (2019-01-01)

Generation of TSC1 knockout induced pluripotent stem cell (iPSC) line
di: Wei Shan, et al.
Pubblicazione: (2022-10-01)

Generation of a heterozygous and a homozygous CSF1R knockout line from iPSC using CRISPR/Cas9
di: Anne S. Schmitz, et al.
Pubblicazione: (2023-06-01)

Generation of a RRAGA knockout human iPSC line GIBHi002-A-5 using CRISPR/Cas9 technology
di: Yilu Sun, et al.
Pubblicazione: (2022-08-01)

Generation of RAB4A homozygous knockout induced pluripotent stem cell (iPSC) line
di: Rui wang, et al.
Pubblicazione: (2024-12-01)

CRISPR/Cas9-mediated Precise SNP Editing in Human iPSC Lines
di: Hanwen Zhang, et al.
Pubblicazione: (2021-06-01)

Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the LMNA gene by CRISPR/Cas9 technology
di: Ji-Zhen Lu, et al.
Pubblicazione: (2021-10-01)

Generation of a homozygous TIGIT gene knockout (TIGIT−/−) human iPSC line (MUSIi001-A-3) using CRISPR/Cas9 system
di: Jakkrapatra Srisantitham, et al.
Pubblicazione: (2024-12-01)

Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system
di: Meiling Jiang, et al.
Pubblicazione: (2023-09-01)

Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages
di: Shuzhong Zhang, et al.
Pubblicazione: (2020-08-01)

Generation of a human Tropomyosin 1 knockout iPSC line
di: Madison B. Wilken, et al.
Pubblicazione: (2023-09-01)

Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome)
di: Baiqiang Wang, et al.
Pubblicazione: (2024-06-01)

Corrigendum to “Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene” [Stem Cell Res. 56 (2021) 102517]
di: Bailing Zu, et al.
Pubblicazione: (2022-07-01)

Generation of a miR-26b stem-loop knockout human iPSC line, MCRIi019-A-1, using CRISPR/Cas9 editing
di: Louise H.W. Kung, et al.
Pubblicazione: (2021-01-01)

Suspension culture improves iPSC expansion and pluripotency phenotype
di: Nerea Cuesta-Gomez, et al.
Pubblicazione: (2023-06-01)

CRISPR/Cas9-mediated engineering of subtype-specific cell lines for iPSC-derived cardiomyocyte phenotyping
di: Sontayananon, N
Pubblicazione: (2022)

Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages.
di: Haenseler, W, et al.
Pubblicazione: (2017)

Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
di: Walther Haenseler, et al.
Pubblicazione: (2017-08-01)

Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system
di: Yu Liu, et al.
Pubblicazione: (2022-05-01)

In vitro quantitative imaging assay for phagocytosis of dead neuroblastoma cells by iPSC-macrophages
di: Hall-Roberts, H, et al.
Pubblicazione: (2021)

Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing
di: Marie-Kristin Schreiber, et al.
Pubblicazione: (2024-02-01)

Generation and characterization of an endogenously tagged SPG11-human iPSC line by CRISPR/Cas9 mediated knock-in
di: Laura Krumm, et al.
Pubblicazione: (2021-10-01)

Generation of induced pluripotent stem cell (iPSC) lines carrying a heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2) of Cadherin 13 associated with neurodevelopmental disorders using CRISPR/Cas9
di: Maria Rosaria Vitale, et al.
Pubblicazione: (2021-03-01)

Large-scale production of human iPSC-derived macrophages for drug screening
di: Gutbier, S, et al.
Pubblicazione: (2020)

Generation of a human ACTA1-tdTomato reporter iPSC line using CRISPR/Cas9 editing
di: Peter J. Houweling, et al.
Pubblicazione: (2024-03-01)

Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9
di: Ambrin Fatima, et al.
Pubblicazione: (2020-04-01)

Three dimensional collagen scaffolds promote iPSC induction with higher pluripotency
di: Qi Gu, et al.
Pubblicazione: (2016-10-01)

Screening Genes Promoting Exit from Naive Pluripotency Based on Genome-Scale CRISPR-Cas9 Knockout
di: Bin Yang, et al.
Pubblicazione: (2020-01-01)

Generation of human induced pluripotent stem cell lines from a subject with UBAP1L-associated retinal dystrophy and CRISPR/cas9-corrected isogenic iPSC lines
di: Andréa Amprou, et al.
Pubblicazione: (2024-12-01)

Generation of a gene corrected human isogenic IBMS-iPSC-014-C from polycystic-kidney-disease induced pluripotent stem cell line using CRISPR/Cas9
di: Chun-Lin Liu, et al.
Pubblicazione: (2020-05-01)

Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing
di: David Diouf, et al.
Pubblicazione: (2023-03-01)

TREM2 Alzheimer’s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages
di: Hall-Roberts, H, et al.
Pubblicazione: (2020)

Generation of a human iPSC line CIBi010-A with a reporter for ASGR1 using CRISPR/Cas9
di: Jian Fu, et al.
Pubblicazione: (2022-07-01)

414 Efficacy and immunogenicity of induced pluripotent stem cell (iPSC) vaccine is independent of iPSC viability in a prophylactic mouse model of breast cancer
di: Hui Huang, et al.
Pubblicazione: (2023-11-01)